PATENT CLAIM ANALYSIS

Application Number: 16005207
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "006110"]

Abstract:
Methods of assessing colorectal adenoma, probes, and a kit.

Claim (Index 9):
A set of detectably labeled probes comprising a locus-specific probe for EGFR (epidermal growth factor receptor), a locus-specific probe for DCC (deleted in colorectal carcinoma), a chromosome enumeration probe for chromosome 18 (CEP18), a locus-specific probe for 13q14 (band 14 on the q arm of chromosome 13), and a locus-specific probe for MYC (c-myc oncogene).

Metadata:
- Claim Count in Document: 10.0
- Percentile: 94.0
- Lexical Diversity: 1.09091
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14207682', '14788195', '16005228', '13721085', '15443499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5466899308594816
- 35 USC 102 Novelty (BERT): 0.5596526410658758
- Combined Prediction Score: 0.547986201880121
- Mean Citation Score: 276.78031
- Max Citation Score: 423.97437
- Similarity Product: 375.08403498744616

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test